BSEGeneral30 Sept 2026 · 30 Sept 2026, 02:54 pm

OUTCOME OF BOARD MEETING HELD ON 30-09-2026

Aarey Drugs & Pharmaceuticals Ltd · 524412

✦ AI SummaryFundraise

Aarey Drugs & Pharmaceuticals Ltd has approved the allotment of 11,50,000 Equity Shares of Rs. 10/- each pursuant to Conversion of Fully Convertible Equity Share Warrants upon receipt of Rs. 47.85/- per warrant.

Analysis Scores

Earnings Impact2/10
Growth Catalyst3/10
Governance Concern1/10
Regulatory Risk2/10
Balance Sheet Risk2/10
Liquidity Impact5/10
Market Sentiment4/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Aarey Drugs & Pharmaceuticals Ltd - 524412 - Board Meeting Outcome for OUTCOME OF BOARD MEETING HELD ON 30-09-2026

Attachments (1)

📄

7ba270a2-88cd-43cc-a51f-3f0f9611e31d.pdf

pdf

Download →
View document text
30-09-2026 To, To, National Stock Exchange of India Ltd., Listing Operation, Exchange Plaza, C-1, Block G, BSE Limited, Bandra Kurla Complex, 20th Floor, P.J.Towers, Bandra (E), Mumbai – 400 051 Dalal Street, Mumbai – 400 001. Sub: Outcome for the Board Meeting held on 30-09-2026 at 11.30 AM and Concluded at 12.30 PM Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for allotment of 11,50,000 Equity Shares pursuant to Conversion of Warrants. Dear Sir/Madam, This is with reference to allotment of 50,00,000 Convertible Warrants of Face Value Rs. 10/- Each on Preferential allotment basis at an Offer Price of Rs. 63.80/- Each and pursuant to members’ approval dated January 02, 2025 the Board of Directors of the Company at its meeting held i.e. 30-09-2026 at 11.30 AM and Concluded at 12.30 PM have approved the allotment of 11,50,000 Equity Shares of Rs. 10/- each pursuant to Conversion of Fully Convertible Equity Share Warrants ("Warrants") upon receipt of Rs. 47.85/- per warrant (being 75% of the issue price i.e. Rs. 63.80/- Per Warrant} aggregating to Rs. 5,50,27,500/- to the persons belonging to both promoter and non-promoter Category. Pursuant to the above allotment, the issued and paid-up capital of the Company shall be as under: Particulars Before Allotment After Allotment in Board After Allotment in Board Meeting 06-08-2026 Meeting 30-09-2026 No. of Value No. of Value No. of Value Shares (FV Rs. 10/-) Shares (FV Rs. 10/-) Shares (FV Rs. 10/-) Issued 28354303 Rs. 283543030/- 30724303 Rs.307243030 31874303 Rs. 318743030/- Capital Paid-up 28354303 Rs. 283543030/- 30724303 Rs. 307243030 31874303 Rs. 318743030/- Capital Pursuant to Regulation 30 and Schedule III of the Listing Regulations, read with the SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024 (“SEBI Disclosure Circular”), the detailed disclosure in respect of the allotment of equity shares pursuant to conversion of warrants is set out below at Annexure-A. Furthermore, read with the outcome of Board Meeting 06-08-2026 please find enclosed revised Annexure I table. Thanking You Yours faithfully, FOR AAREY DRUGS AND PHARMACEUTICLES LIMITED NIMIT GHATALIA DIRECTOR DIN: 07069841 Encl.: As Above ANNEXURE A SR. PARTICULARS OF SECURITIES DETAILS a. Type of Securities Issued Equity Shares issued upon exercise of the convertible warrants b. Type of Issue Equity shares issued upon exercise of the Convertible Warrants which were issued by way of a preferential allotment. c. Issue Price Rs. 63.80/- per warrant (at Premium of Rs. 53.80/-) as determined in accordance with Chapter V of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018 ("SEBI ICDR Regulations") d. In case of preferential issue, the listed entity shall disclose the following additional details to the stock exchange(s):- 1. Name of Investors and their As Per Annexure I & Annexure II corresponding subscription of No. of Warrants 2. In case of convertibles - Exercise of 50,00,000 fully convertible warrants into 50,00,000 intimation on conversion of fully paid-up Equity Shares of the Company of FV Rs. 10 /- Each. securities or on lapse of the Tenure for Conversion into Equity Shares is 18 months from the tenure of the instrument; date of allotment i.e. 23-05-2025. 1. 23,70,000 Convertible Warrants Converted into Equity Shares in the Board Meeting held on 06-08-2026. 2. 11,50,000 Convertible Warrants Converted into Equity Shares in the Board Meeting held on 30-09-2026 3. 14,80,000 Convertible Warrants Outstanding for Conversion into Equity Shares within 18 Months from date of allotment i.e. 23-05-2025. Annexure I: List of Allottees to whom Equity Shares are Allotted pursuant to Conversion of Warrants as on 06-08-2026: Sr. No. Name Pre- Pre No. Of No. Of Post Post Category holding holding warrants Warrants allotment holding % % Allotted Converted holding on 23-05- into Equity 2025 Promoter & Bina Rajesh 1 4003584 14.12% 500000 500000 4503584 14.66% Promoter Ghatalia Group Mihir Promoter & 2 Rajesh 2835888 10.00% 345000 345000 3180888 10.35% Promoter Ghatalia Group Nimit Promoter & 3 Rajesh 1150000 4.06% 500000 350000 1500000 4.88% Promoter Ghatalia Group Promoter & Mira Mihir 4 690000 2.43% 250000 250000 940000 3.06% Promoter Ghatalia Group Promoter & Ekta Nimit 5 0 0.00% 500000 500000 500000 1.63% Promoter Ghatalia Group Mihir Promoter & Rajesh 6 0 0.00% 245000 245000 245000 0.80% Promoter Ghatalia Group (HUF) Rajesh Promoter & 7 Pranlal 2,971 0.01% 180000 180000 182971 0.60% Promoter Ghatalia Group Enam Promoter & Organics 8 0 0.00% 345000 0 0 0.00% Promoter India Group Limited Sr. No. Name Pre- Pre No. Of No. Of Post Post Category holding holding warrants Warrants allotment holding % % Allotted Converted holding on 23-05- into Equity 2025 Nimit Impex Promoter & 9 Private 2010000 7.09% 345000 0 0 0.00% Promoter Limited Group Suraj Promoter & Tradelinks 10 0 0.00% 345000 0 0 0.00% Promoter Private Group Limited Worth Investment Promoter & 11 and Trading 0 0.00% 345000 0 0 0.00% Promoter Company Group Limited Archana 12 Pramod 0 0.00% 200000 0 0 0.00% Public Wani Priti 13 Vijaykumar 0 0.00% 500000 0 0 0.00% Public Shah Vaishali 14 0 0.00% 250000 0 0 0.00% Public Aggarwal Mamta 15 Girish 500 0.00% 100000 0 0 0.00% Public Chheda Sujata 16 Tushar 0 0.00% 25000 0 0 0.00% Public Mehta Tushar 17 0 0.00% 25000 0 0 0.00% Public Mehta Huf Annexure I: List of Allottees to whom Equity Shares are Allotted pursuant to Conversion of Warrants as on 30- 09-2026: Sr. No. Name Pre- Pre No. Of Post Post Category holding holding Warrants allotment holding % % Converted holding into Equity 30-09- 2026 1 Bina Rajesh Promoter & 4503584 14.66 0 4503584 14.13% Ghatalia Promoter Group 2 Mihir Rajesh Promoter & 3180888 10.35 0 3180888 9.98% Ghatalia Promoter Group 3 Nimit Rajesh Promoter & 1500000 4.88 150000 1650000 5.18% Ghatalia Promoter Group 4 Mira Mihir Promoter & 940000 3.06 0 940000 2.95% Ghatalia Promoter Group 5 Ekta Nimit Promoter & 500000 1.63 0 500000 1.57% Ghatalia Promoter Group 6 Mihir Rajesh Promoter & Ghatalia (HUF) 245000 0.80 0 245000 0.77% Promoter Group 7 Rajesh Pranlal Promoter & 182971 0.60 0 182971 0.57% Ghatalia Promoter Group 8 Enam Organics Promoter & 0 0.00 0 0 0.00% India Limited Promoter Group 9 Nimit Impex Promoter & 0 0.00 0 2010000 6.31% Private Limited Promoter Group 10 Suraj Tradelinks Private Limited Promoter & 0 0.00 0 0 0.00% Promoter Group 11 Worth Investment and Promoter & 0 0.00 0 0 0.00% Trading Company Promoter Group Limited Sr. No. Name Pre- Pre No. Of Post Post Category holding holding Warrants allotment holding % % Converted holding into Equity 30-09- 2026 12 Archana Pramod 0 0.00 200000 200000 0.63% Public Wani 13 Priti Vijaykumar 0 0.00 500000 500000 1.57% Public Shah 14 Vaishali Aggarwal 0 0.00 250000 250000 0.78% Public 15 Mamta Girish 0 0.00 0 0 0.00% Public Chheda 16 Sujata Tushar 0 0.00 25000 25000 0.08% Public Mehta 17 Tushar Mehta 0 0.00 25000 25000 0.08% Public FOR AAREY DRUGS AND PHARMACEUTICLES LIMITED NIMIT GHATALIA DIRECTOR DIN: 07069841